Skip to main content
All lobbying filings

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Lobbying for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION · no change

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $4,112,554.00 expenses · posted Apr 21, 2025

Official filing document

 Bills named in this filing 16
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • HR 2214
    DRUG Act
  • HR 2450
    Prescription Drug Transparency and Affordability Act
  • HR 950
    Saving Seniors Money on Prescriptions Act
  • HR 2041
    Hidden Fee Disclosure Act of 2025
  • S 864
    HELP Copays Act
  • S 882
    Patients Before Middlemen Act
  • S 927
    Protecting Pharmacies in Medicaid Act
  • S 832
    EPIC Act of 2025
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1040
    Drug Competition Enhancement Act
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S 527
    Prescription Pricing for the People Act of 2025
  • S 1095
    Stop STALLING Act
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
  • S 2484
    Expanding Nationwide Access to Test Strips Act
 Lobbying activity 3
Medicare/Medicaid

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

Health Issues

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

Pharmacy

H.R. 1968, Full-Year Continuing Appropriations and Extensions Act of 2025 H.R. 2214 Delinking Revenue from Unfair Gouging Act H.R.2450, the Prescription Drug Transparency and Affordability Act H.R. 950, the Saving Seniors Money on Prescriptions Act H.R.2041, the Hidden Fee Disclosure Act S. 864 Help Ensure Lower Patients (HELP) Copays Act S. 882 Patients Before Middlemen Act S. 927 Protecting Pharmacies In Medicaid Act S. 832 Ensuring Pathways to Innovative Cures (EPIC) Act S. 1041 Affordable Prescriptions for Patients Act S.1040 Drug Competition Enhancement Act S.526, the Pharmacy Benefit Manager Transparency Act S.527, the Prescription Pricing for the People Act S.1095, the Stop STALLING Act S.1302, the Increasing Transparency in Generic Drug Applications Act S.2484, the Seniors Access to Critical Medications Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem